Concurrent Use of Mifepristone and Misoprostol for Early Medical Abortion
Objective: This study was designed to evaluate the efficacy of using mifepristone and misoprostol concurrently for early medical abortion. Materials and Methods: A total of 90 women with undesired pregnancies ≤ 49 days' gestation were enrolled. All women concurrently received oral mifepristone...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2006-12-01
|
| Series: | Taiwanese Journal of Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1028455909602527 |
| Summary: | Objective: This study was designed to evaluate the efficacy of using mifepristone and misoprostol concurrently for early medical abortion.
Materials and Methods: A total of 90 women with undesired pregnancies ≤ 49 days' gestation were enrolled. All women concurrently received oral mifepristone 200 mg and vaginal misoprostol 800 mg. Follow-up evaluation with transvaginal ultrasonography was performed 4 days and 2 weeks after treatment.
Results: The complete abortion rate was 97.8% (88/90 women). The mean induction to abortion interval was 5.5 hours. The mean bleeding duration was 11.8 days. Patients found the side effects acceptable and reported a 91.1% (82 patients) satisfaction rate.
Conclusion: Concurrent administration of oral mifepristone and vaginal misoprostol is an efficacious regimen for medical abortion of pregnancies ≤ 49 days of gestation. |
|---|---|
| ISSN: | 1028-4559 |